Webinar
Large Molecule Pharmacokinetic Assays for New Modalities
PK assays are a vital component of the drug development process and the data derived is utilized to help select the dosage for preclinical and…
Translational Medicine in Drug Development
In association with Oxford Global, this webinar will highlight how to properly structure your program and get an in-depth look at the critical parameters needed…
Bioanalytical Strategies for Biomarker Implementation in Clinical Trials
In association with Bioanalysis Zone, this webinar will highlight how bioanalytical strategies for implementing biomarkers in clinical trials will be presented. The increased use of…
Gyrolab®: Case Studies in Assay Development and Validation
In association with Bioanalysis Zone, BioAgilytix would like to present Gyrolab, a platform that provides a highly automated platform that optimizes immunoassays for use at…
Full-Service Bioanalysis of an Immuno-oncology Program
In association with Bioanalysis Zone, BioAgilytix’s Chief Scientific Officer, Dr. Jim McNally provides an overview of the support for immuno-oncology programs by BioAgilytix, addressing pharmacokinetics,…
Bioanalytical Testing for Gene Therapy Webinar
MassBio and BioAgilytix would like to welcome you to our February webinar. This interactive discussion will feature a live Q&A session and include insight from…
Immediate Hypersensitivity Reactions Against Biologicals
In associate with Bioanalysis Zone, BioAgilytix’s Chief Scientific Advisor, Dr. Arno Kromminga, and Principal Investigator, Dr. Janett Schwarz, discuss the observation of drug-specific IgE antibodies,…
Impact of Pre-Existing Immunogenicity Against AAV on Gene Therapy Trials
BioAgilytix’s Chief Scientific Officer, Dr. Jim McNally, shares scientific insight focused on the assessment of pre-existing antibodies to the AAV viral capsid and the implications…
How to Apply Fit-for-Purpose Biomarker Assay Validation to Your COU
In this live webinar, our experts will discuss how drug development success rate can be increased by the use of biomarkers, and thereby accelerate the…